Literature DB >> 23040356

BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.

Monika D Kraszewska1, Małgorzata Dawidowska, Maria Kosmalska, Lukasz Sędek, Władysław Grzeszczak, Jerzy R Kowalczyk, Tomasz Szczepański, Michał Witt.   

Abstract

T-cell acute lymphoblastic leukemia is a heterogeneous malignancy originating from developing lymphocyte precursors likely due to mutations in genes regulating thymocyte differentiation. Here, we characterized mutation status of BCL11B and FLT3 genes, presumably involved in T-ALL, together with FBXW7 and NOTCH1 as known players in T-ALL in 65 pediatric T-cell acute lymphoblastic leukemia patients. We also aimed at the assessment of prognostic value of NOTCH1 and FBXW7 mutations in ALL-IC BFM 2002 protocol. FLT3 and BCL11B mutations were detected in 3% and 2% of patients, respectively. FBXW7 mutations were observed in 8% of patients, while NOTCH1 was mutated in 40%. No correlation was found between NOTCH1 and FBXW7 mutations and traditionally used clinical factors or molecular features. In total we have detected nine mutations, which have not been previously described by others. Eight of them were found in NOTCH1 and one in BCL11B gene. Observed frequencies of NOTCH1 and FBXW7 are in line with previous reports, thus confirming postulated participation of these two genes in T-ALL pathomechanism. Moreover, we report on mutation frequency of FLT3 and BCL11B, not extensively studied in T-ALL so far. Finally, we suggest a putative role of BLC11B as an oncogene in T-ALL pathogenesis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23040356     DOI: 10.1016/j.bcmd.2012.09.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  7 in total

1.  Detection of microvesicle miRNA expression in ALL subtypes and analysis of their functional roles.

Authors:  Wen-Ying Li; Xiao-Mei Chen; Wei Xiong; Dong-Mei Guo; Li Lu; Hui-Yu Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

Review 2.  SWI/SNF chromatin remodeling complexes and cancer.

Authors:  Jaclyn A Biegel; Tracy M Busse; Bernard E Weissman
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-08-28       Impact factor: 3.908

3.  Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemia.

Authors:  Uri Rozovski; Ping Li; David Harris; Maro Ohanian; Hagop Kantarjian; Zeev Estrov
Journal:  Cancer Med       Date:  2014-03-26       Impact factor: 4.452

4.  Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.

Authors:  Isabelle Bartram; Nicola Gökbuget; Cornelia Schlee; Sandra Heesch; Lars Fransecky; Stefan Schwartz; Reingard Stuhlmann; Kerstin Schäfer-Eckhart; Michael Starck; Albrecht Reichle; Dieter Hoelzer; Claudia D Baldus; Martin Neumann
Journal:  J Hematol Oncol       Date:  2014-07-15       Impact factor: 17.388

5.  SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.

Authors:  Patricia Johansson; Ludger Klein-Hitpass; Axel Choidas; Peter Habenberger; Bijan Mahboubi; Baek Kim; Anke Bergmann; René Scholtysik; Martina Brauser; Anna Lollies; Reiner Siebert; Thorsten Zenz; Ulrich Dührsen; Ralf Küppers; Jan Dürig
Journal:  Blood Cancer J       Date:  2018-01-19       Impact factor: 11.037

6.  Overexpression of CD59 inhibits apoptosis of T-acute lymphoblastic leukemia via AKT/Notch1 signaling pathway.

Authors:  Yanfei Jia; Yan Qi; Yunshan Wang; Xiaoli Ma; Yihui Xu; Jun Wang; Xiaoqian Zhang; Meihua Gao; Beibei Cong; Shuyi Han
Journal:  Cancer Cell Int       Date:  2019-01-08       Impact factor: 5.722

Review 7.  Comprehensive Overview of Gene Rearrangements in Childhood T-Cell Acute Lymphoblastic Leukaemia.

Authors:  Anna Mroczek; Joanna Zawitkowska; Jerzy Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.